Document Actions
F V Aguirre, E J Topol, K M Anderson, N S Kleiman, H F Weisman, S E FitzPatrick, and R M Califf (1996)
Clinical benefit within patient subgroups receiving c7E3 Fab (abciximab) during percutaneous coronary revascularization: subgroup analysis from the EPIC trial
Up one level
Last modified
February 02, 2007 09:20 AM - EST
.
automatic medline import
Link to PubMed entry